Growth Arrest-Specific Factor 6 (GAS6) Is Increased in COVID-19 Patients and Predicts Clinical Outcome.

Albert MoralesSilvia Rojo RelloHelena CristóbalAida Fiz-López Elisa Arribas Montserrat Marí Anna TutusausPaloma de la Cal-SabaterGerry A F NicolaesJosé T Ortiz-PérezDavid BernardoPablo García de Frutos

Published in: Biomedicines (2021)

Plasma GAS6 and AXL levels reflect COVID-19 severity and could be early markers of disease prognosis, supporting a relevant role of the GAS6/AXL system in the immune response in COVID-19.

Keyphrases

sars cov
coronavirus disease
room temperature
immune response
tyrosine kinase
carbon dioxide
respiratory syndrome coronavirus
cell cycle
toll like receptor
cell proliferation